GlucoTrack Inc
(NASDAQ: GCTK)

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

6.190

+0.210 (+3.51%)
Range 6.019 - 6.190   (2.84%)
Open 6.019
Previous Close 5.980
Bid Price 0.432
Bid Volume 10
Ask Price 0.440
Ask Volume 11
Volume 1,722
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:54.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis